Monoclonal antibodies as pharmacokinetic antagonists for the treatment of (+)-methamphetamine addiction.
CNS Neurol Disord Drug Targets. 2011 Dec;10(8):892-8. doi: 10.2174/187152711799219370.
CNS Neurol Disord Drug Targets. 2011.
PMID: 22229314
Free PMC article.
Review.